Berlin, Germany

ICBC B2B

Thanks To All Who Participated And Attended The Conference &For Being A Part Of This Great Success!

BERLIN B2B

ICBC BERLIN 2021 SCHEDULE

26-27 AUGUST 2021

THURSDAY, 26 AUGUST 2021

  • 8:45

    ICBC Conference Overview

Alex Rogers, Executive Producer of the International Cannabis Business Conference, welcomes conference attendees and provides an overview of the conference schedule, including the panels and speakers that will be providing presentations and interviews.

Alex Rogers

Alex Rogers

CEO & EXECUTIVE PRODUCER, ICBC
  • 9:00

    Keynote Speaker, Jamie Pearson

Jamie L. Pearson is the President & CEO of Bhang Inc.  A rare, second-generation cannabis executive, she has decades of experience in global operations, deal structuring and negotiation as a former multi-national real estate entrepreneur and investor. Fluent in German and English, Jamie is responsible for Bhang's capital markets initiatives, national and international expansion, and overall corporate management. She leads the company's diverse executive team in the development and execution of Bhang's strategic plan.

Jamie Pearson

Jamie Pearson

PRESIDENT & CEO, BHANG INC
  • 9:30

    Germany and Europe Medical Cannabis Regulations Update

The latest and most important information regarding cannabis regulations in Europe

Peter Homberg, a partner at Dentons Law Firm, will provide a thorough update regarding medical cannabis regulations and trends in Germany and Europe. Topics will include supply and demand in Germany and Europe, the German tender process regarding national cultivation of medical cannabis, cannabis exports/imports, price models, and potential harmonization of cannabis products within the EU.

Peter Homburg

Peter Homberg

PARTNER, DENTONS • HEAD OF EUROPEAN CANNABIS GROUP
  • 10:15

    Upcoming Elections In Germany

Cannabis for sale - the state of Europe's leading market

Jürgen Neumeyer

Jürgen Neumeyer

MANAGING DIRECTOR OF BRANCHENVERBAND CANNABISWIRTSCHAFT E.V. (BVCW)

MODERATOR
Dr. Wieland Schinnenburg

Dr. Wieland Schinnenburg, MdB

MEMBER OF THE GERMAN BUNDESTAG, (FDP - LIBERAL PARTY)

Erwin Rüddel

Erwin Rüddel

CHAIRMAN OF THE GERMAN BUNDESTAG'S COMMITTEE ON HEALTH, (CDU)

Burkhard Blienert

Burkhard Blienert

FORMER MEMBER OF THE GERMAN BUNDESTAG, (SPD)

Niema Movassat

Niema Movassat

MEMBER OF THE GERMAN BUNDESTAG, (DIE LINKE)

Werner Graf

Werner Graf

STATE CHAIRMAN BÜNDNIS 90/DIE GRÜNEN BERLIN, (GREEN PARTY)

Public policy experts representing all major political parties in Germany will participate in this panel discussion hosted by the German Cannabis Business Association (Branchenverband Cannabiswirtschaft e.V. - BvCW). The political framework of four key policy areas will be discussed. Topics will include the future of medical cannabis policy in Germany, hemp as a renewable resource, necessary framework conditions for CBD (and other cannabinoids), and anticipating needed changes after the upcoming federal election. This panel discussion will be held in German.

  • 11:15

    Focus on the Cannabis Pharmacy

Pharmacies are the backbone of Germany's cannabis industry

Tobias Lau

Tobias Lau

JOURNALIST, EDITOR AT APOTHEKE ADHOC

MODERATOR
Florian Heimann

Florian Heimann

CO-FOUNDER CANNABIS-APOTHEKE.DE

Sita Schubert

Sita Schubert

SECRETARY GENERAL, EUROPEAN MEDICINAL CANNABIS ASSOCIATION (EUMCA)

Melanie Dolfen

Melanie Dolfen

OWNER OF THE BEZIRKSAPOTHEKEN AND GESUNDBAR IN BERLIN

Four years after the introduction of medical cannabis in Germany the market continues to develop rapidly, and pharmacies and patients often struggle to keep up due to regulatory shortcomings and unnecessary restrictions. Pharmacies continue to serve as the main distributors of medical cannabis in Germany. This panel will discuss Germany's current distribution model, ways to improve performance and supply, and how adult-use cannabis legalization may impact medical cannabis distribution.

  • 12:00

    German Distribution and Import and Sales

Obtaining shelf space in the marketplace

Xenia von Maltzan

Xenia von Maltzan

CUSTOMER RELATIONS MANAGER, PROPHARMA GROUP

MODERATOR
Cornelius Maurer

Cornelius Maurer

FOUNDER, DEMECAN

Dr. Alessandro Rossoni

Alessandro Rossoni

CO-FOUNDER AND MANAGING DIRECTOR OF NIMBUS HEALTH

Tony Schroeter

Tony Schroeter

BOARD MEMBER AND HEAD OF GROUP COMPLIANCE, WEECO HOLDING GMBH

Benedikt Sons

Benedikt Sons

CO-FOUNDER AND CEO OF CANSATIVA

The German medical cannabis market is one of the most valuable in the world - but unique challenges exist in navigating it successfully. Learn from the experts about what it takes to get your cannabis and products into the market and what leads to ongoing sales strategies that work.

  • 12:45

    European CBD Industry and Policy Update

The most important information that you need to know about CBD regulations

Tobias Lau

Tobias Lau

JOURNALIST, EDITOR AT APOTHEKE ADHOC

MODERATOR
Bostjan Jancar

Boštjan Jančar

CHIEF TECHNOLOGY OFFICER, PHARMAHEMP

Jan Peter Witte

Jan Peter Witte

MANAGING DIRECTOR VAYAMED AND DIRECTOR MEDICAL SANITY GROUP

Sebastian Kamphorst

Sebastian Kamphorst

CO-FOUNDER & CEO BECANEX GmbH

The last two years have been a roller coaster ride for companies selling and developing CBD products – from the EU officially considering CBD as a narcotic, to its highest court ruling that it is exactly not a narcotic. Now the trend points to the liberalization of CBD regulation, which provides new opportunities for those companies but also opens up some new challenges. So where is the CBD market going? How does regulation still need to be reformed? How can providers of CBD products in pharmaceutical quality position themselves?

  • 13:30

    Break

  • 14:30

    Homogenizing the Cannabis Industry Regulatory Environment

Streamlining rules and regulations in the midst of an evolving industry

Benjamin Patock

Benjamin Patock

HEAD OF INTERNATIONAL RELATIONS, BOVEDA

MODERATOR
Lewis Koski

Lewis Koski

CHIEF OPERATING OFFICER, METRC

Luc Richner

Luc Richner

CEO FOUNDER, CANNAVIGIA

Daniel McMillan

Daniel McMillan

SCIEX SR MARKET DEVELOPMENT MANAGER - FOOD, ENVIRONMENT & FORENSIC - EMEAI

The international industry requires homogenization of standards to continue to flourish. This includes between continents, but it also includes regions like Europe, and after federal reform, the United States. How does the industry achieve this in an environment where legalization is still moving forward at different stages of maturity, and where to start?

  • 15:00

    GMP - What Does This Really Mean?

Harmonization of global medical standards through the eyes of cannabusiness experts

Michael Knodt

Michael Knodt

FREELANCE JOURNALIST

MODERATOR
Nima Kaempf

Nima Kaempf

CEO CHARLIE'S LAB AND SWISS HEMPCARE

Peter Sigetty

Peter Sigetty

COO, VALCON MEDICAL

GMP is one of the largest issues facing the international medical and increasingly recreational market. Uniform GMP legislation already exists in Europe. For  companies aiming to enter the European cannabis market, EU-GMP is essential. What are the chances and problems seen by consultants and regulators as GMP regulations are homogenized within the EU, but differ across international borders?

  • 15:30

    Understanding Novel Food

Bringing new and innovative cannabis food products to the EU

Lisa Haag

Lisa Haag

FOUNDER MJ_UNIVERSE

MODERATOR
Kai-Friedrich Niermann

Kai-Friedrich Niermann

KFN+ LAW OFFICE, FOUNDER

Francis Scanlan

Francis Scanlan

FOUNDER AND MANAGING DIRECTOR, CLOUD 9 SWITZERLAND LLC

Marjeta Cesen

Marjeta Česen

CHIEF REGULATORY AFFAIRS OFFICER, PHARMAHEMP

Despite many commonalities in legislation and a desire for a single European market, the emerging cannabis industry is still regulated by a patchwork of national laws. Cannabis is produced in countries such as Denmark, Switzerland, Portugal, Germany, and the Netherlands under varying regulatory frameworks, and thus also differing economic conditions. Will there eventually be a market where the same rules and laws apply to everyone on the European continent? Our panel experts will report from their own experiences and provide an outlook on the long-term prospects for a single European cannabis market.

  • 16:15

    The Cannabis Industry in Germany: An Intellectual Property Perspective

Protecting your concept in a hyper-competitive industry

What are the challenges in advertising cannabis and CBD products in Germany?How do you trademark your Cannabis brand in Germany and Europe? What are the key points for brand protection?

Margret Knitter

Margret Knitter

LAWYER, SPECIALIST IN INTELLECTUAL PROPERTY, SKW SCHWARZ RECHTSANWÄLTE
  • 16:30

    Snapshot of the EU Cannabis Marketplace

What is the current status of the EU cannabis market and where is the market headed?

Demand for legal cannabis products is ramping up as cannabis reform continues to spread across the European continent. This presentation led by top cannabis industry economist Beau Whitney will highlight the various legalization initiatives in the EU as well as provide a snapshot of the current CBD and THC markets in various European countries. Whitney will also provide a forecast of what to expect in the emerging legal cannabis market in Europe in the coming years.

Beau Whitney

Beau Whitney

CHIEF REVENUE OFFICER, MANTIS GROWTH INVESTMENTS
  • 17:00

    Investing in Cannabis and Hemp

Matthew Nordgren, Founder and Managing Partner of Arcadian Capital, a venture capital firm investing in the ancillary sector of the cannabis industry, will be giving a 20-minute presentation on his expertise in investing in cannabis and hemp companies, the strategy he believes is the most ideal in the cannabis space, and projections for the next few years. This presentation will give the audience insight on the investment landscape of the cannabis industry, the milestones to come, and where it is headed in the US and globally.

Matthew Nordgren

Matthew Nordgren

CEO & MANAGING PARTNER, ARCADIAN FUND MANAGEMENT, ARCADIAN CAPITAL PARTNERS

FRIDAY, 27 AUGUST 2021

  • 9:30

    Keynote Speaker, Giadha DeCarcer

The latest and most important information regarding cannabis regulations in Europe

Identifying and properly analyzing emerging cannabis industry trends can provide valuable insight that could help change the trajectory of a cannabis company. Giadha A. DeCarcer, founder and executive chair of New Frontier Data, will discuss macro trends in the cannabis industry, focusing on non-endemic brands entering the space and implications for investment, consolidation and consumer engagement. DeCarcer is an entrepreneur with over 20 years of experience in business execution, management, and strategic business development.

Giadha DeCarcer

Giadha DeCarcer

FOUNDER AND EXECUTIVE CHAIR OF NEW FRONTIER DATA
  • 10:00

    Know the Rules to Play the Game

How to Navigate the Complex and Competitive Landscape of the EU and Global Cannabis Markets to Succeed and Thrive

As the EU and global market recovers and expands post-pandemic, fantastic business opportunities are opening up with new licensed medical operations, the Dutch Weed Experiment, ancillary markets and investments, and the hemp sector. International laws are essentially the referees of the game, and it is imperative that as new doors open, businesses stay compliant with the ever-evolving regulations and GXP standards for cultivation, processing and manufacturing of consumer packaged goods, as well as the global importation and exportation of these products. Join Nic Easley, CEO of 3C Consulting and Managing Director of Multiverse Capital, as he coaches entrepreneurs and investors with strategic plays that he’s executed for over a decade on the inside of the operational and investment arenas of the global industry. Nic will share techniques for raising capital, starting new businesses, and investing in the areas with the most potential for long-term success. Nic will also explore the trends throughout Germany, Europe, and other international markets and educate you from the playbooks of North American and International successes and failures.

Nic Easley

Nic Easley

CEO, MULTIVERSE CAPITAL
  • 10:30

    Doing Business Internationally

Making a global splash in the emerging international cannabis industry

Michael Knodt

Michael Knodt

FREELANCE JOURNALIST

MODERATOR
Rodolphe Ruffie

Rodolphe Ruffie

SENIOR ASSOCIATE, CLIFFORD CHANCE

Pete Patterson

Pete Patterson

CEO, VALCON MEDICAL

The cannabis industry is now fully international. Biomass and products are being shipped globally. However, this is one of the most difficult and complicated parts of the entire industry. Learn from the experts what it takes to enter the international industry and what the biggest challenges still are in shipping cannabinoids across borders.

  • 11:15

    Emerging Markets

Which markets in Europe have the most potential and opportunity?

Marguerite Arnold

Marguerite Arnold

ENTREPRENEUR, INFLUENCER, JOURNALIST

MODERATOR
Stephen Murphy

Stephen Murphy

CEO AND CO-FOUNDER OF PROHIBITION HOLDINGS

Kostas Ioannou

Kostas Ioannou

BUSINESS DEVELOPMENT REPRESENTATIVE, VITALIS EXTRACTION TECHNOLOGY

Boniface Dube

Boniface Dube

BIONOMINAL COEFFICIENTS GROUP (BCG)

Paul Smerda

Paul Smerda

BUSINESS DEVELOPMENT MANAGER, NEW ZEALAND TRADE AND ENTERPRISE

Add cannabis to emerging market dynamics and you have the recipe for economic development on steroids. Learn from the experts about what is going on in places like Poland, Greece and other emerging markets that are also on the brink of cannabis reform.

  • 12:15

    Medical Cannabis Education

Reducing the stigma of a proven medicine

Moritz Förster

Moritz Förster

FOUNDER KRAUTINVEST.DE and PR-LEAD AT OPENERS

MODERATOR
Daniel Gauci

Daniel Gauci

CHIEF BUSINESS DEVELOPMENT OFFICER, HEAD OF CONTENT, JUICY FIELDS

Božidar Radišič

Božidar Radišič

PROJECT MANAGER AND FOUNDER, RESEARCH NATURE INSTITUTE

Julian Wichmann

Julian Wichmann

FOUNDER & CEO, ALGEA CARE

Doctor education has finally started to come to Europe - but what exactly does this mean? Beyond doctors however, what else is necessary from the industry to change perceptions of the plant and cannabinoid medicines - and at all levels - from national governments to municipal leaders, not to mention patients, insurers, and regulators?

  • 13:00

    Break

  • 14:00

    Road to Legalization

What will cannabis legalization look like in Germany?

Rebecca Wiegärtner

Rebecca Wiegärtner

FOOD & RETAIL BUSINESS CONSULTANT

MODERATOR
Lisa Haag

Lisa Haag

FOUNDER MJ_UNIVERSE

Jan Witte

Jan Witte

MANAGING DIRECTOR VAYAMED AND DIRECTOR MEDICAL SANITY GROUP

Burkhard Blienert

Burkhard Blienert

FORMER MEMBER OF THE GERMAN BUNDESTAG, (SPD)

Germany is at the brink of getting a new government, and the word is that it will most probably include the Green Party. Therefore, the prospects for the legalization of recreational Cannabis use have never been better than now. But if so – then how? Most probably Germany would start with at least some kind of pilot projects like distribution via pharmacies and then end up in some highly regulated market. So, what are the role models for legalization German lawmakers look at? What can Cannabis companies expect? And how should they prepare for it?

  • 14:30

    Cannabis Technology

Revolutionizing an Emerging Industry

Marguerite Arnold

Marguerite Arnold

COFOUNDER, MEDPAYRX AND CANNACLEAR

MODERATOR
Ziya Gaziyev

Ziya Gaziyev

FOUNDER AND CEO OF HELLOMARY

Marc Plinke

Marc Plinke

OWNER, CERES GREENHOUSE SOLUTIONS

Lucas Targos

Lucas Targos

VICE PRESIDENT OF
FACILITY INTEGRATION
URBAN-GRO, INC.

Tobias Meller

Tobias Meller

FOUNDER TINY TECHNOLOGIES GmbH

Cannatech. Technology and cannabis are continuing to merge. In Europe this falls under both the rubric of digital healthcare as well as certification, production and processing procedures (like GMP). Find out what some of the bigger issues are across the European and British cannatech space as well as some of the companies which are stepping up to meet the challenge.

  • 15:15

    Being A Voice For The Cannabis Industry

Making sure that the industry has a seat at the table

Clinton Younge

Clinton Younge

PRESIDENT, CHARLIE'S PHARMACY

MODERATOR
Michael Correia

Michael Correia

DIRECTOR OF GOVERNMENT RELATIONS FOR THE NATIONAL CANNABIS INDUSTRY ASSOCIATION

Georg Wurth

Georg Wurth

LEADER OF THE GERMAN HEMP ASSOCIATION (DHV)

Finn Hänsel

Finn Hänsel

FOUNDER AND MANAGING DIRECTOR OF SANITY GROUP, MD

Marijn Roersch van der Hoogte

Marijn Roersch van der Hoogte

VICE PRESIDENT, GERMAN CANNABIS BUSINESS ASSOCIATION

New cannabis rules, regulations, and laws are being crafted all over the globe right now, and in jurisdictions where the cannabis industry is already allowed to legally operate policy updates are being drafted and implemented on an ongoing basis. It is absolutely vital that the emerging cannabis industry has a voice in every policy discussion to ensure that the industry's concerns and needs are properly conveyed to policymakers and industry regulators. This panel of cannabis lobbying experts will discuss the importance of cannabis industry lobbying as well as provide guidance regarding how to be an effective lobbyist.

  • 16:00

    Future of the Global Cannabis Industry

From Taboo to Typical

Shane MacGuill

Shane MacGuill

GLOBAL LEAD - NICOTINE AND CANNABIS, EUROMONITOR INTERNATIONAL

Spiros Malandrakis

Spiros Malandrakis

HEAD OF RESEARCH – ALCOHOLIC DRINKS AND CANNABIS, EUROMONITOR INTERNATIONAL

Beyond the haze of hype and dramatic share price fluctuations, the cannabis industry is incrementally penetrating into the realms of FMCG through geographic expansion, democratisation and the adoption of innovative formats and branding sophistication. This session will explore the future evolution of the global cannabis industry - as it sheds its mantle of illicit associations - across markets, consumers and brand propositions. Leveraging proprietary data, deep industry and FMCG expertise, expect a roadmap and vision for the emerging market opportunities, demographic profiles and lifestyle positioning which will shape global cannabis as it comes of age.

  • 16:30

    Marketing and Media

Getting positive attention for your innovative concepts

Michael Knodt

Michael Knodt

FREELANCE JOURNALIST

MODERATOR
Petra Marinko

Petra Marinko

FOUNDER AND OWNER, PHARMA G, NABIE

Mike Wise

Mike Wise

FILMMAKER, PUBLIC SPEAKER, GONZO JOURNALIST,
MEDICINE MAN

Jurij Butina

Jurij Butina

COO, SNAIL CUSTOM ROLLING PAPERS

Stand out, be different, be unique. How important is the visual part of identity, what are psychological aspects and how important is product placement? Useful design and marketing tips and tricks can help you persuade your customers to buy your products or services instead of your competitors. Mass market, online stores, drug stores, B2B, B2C, private label, white label all require different approaches. Our panel of marketing and design experts break down the key aspects of how you can distinguish your brand from every other.

ICBC

The best in cannabis networking!

ICBC International Cannabis Business Conference
JOIN OUR COMMUNITY

© 2014- International Conferences Group | All rights reserved | Site developed and hosted by Rogue Web Works